![Podcast Cover](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/837de7d1c93c6fcd26b53971ca84a44a.jpg)
Contacts
Info
In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and...
show moreWe interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis.
For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums
![Podcast Cover](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/837de7d1c93c6fcd26b53971ca84a44a.jpg)
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
-
What is a Bone Marrow Transplant?
12 JUN 2024 · Dr. Marco Ruiz explains the concept of bone marrow transplant, and how it is used in treating blood cancers. -
Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?
10 JUN 2024 · Drs. Goodman, Phillips, Taneja, and Rajeeve discuss whether a patient's location can affect the treatments they can access and their overall prognosis. -
Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?
5 JUN 2024 · Drs. Goodman, Phillips, Taneja, and Rajeeve discuss how to navigate treatment and Covid vaccination. -
Bispecific Antibodies in Myeloma: Approvals and Clinical Trials
31 MAY 2024 · Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials. -
Curative Strategies for Patients with Smoldering Multiple Myeloma
23 MAY 2024 · Dr. Alankrita Taneja examines data from the CESAR trial, and discusses curative strategies for Smoldering Multiple Myeloma. -
Management of Bispecific Antibodies Side Effects
17 MAY 2024 · Dr. Sridevi Rajeeve discusses possible side effects from bispecific antibodies, and how to manage them. -
Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data
10 MAY 2024 · Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data. -
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
3 MAY 2024 · Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL) -
Barriers to Biomarker Testing: Cost and Insurance
27 APR 2024 · Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing. -
Barriers to Biomarker Testing: Ordering Tests
20 APR 2024 · Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC
In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and...
show moreWe interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis.
For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums
Information
Author | cancerGRACE |
Categories | Medicine |
Website | cancerGRACE.org |
info@cancergrace.org |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company